1. Home
  2. ED vs A Comparison

ED vs A Comparison

Compare ED & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Edison Inc.

ED

Consolidated Edison Inc.

HOLD

Current Price

$95.57

Market Cap

34.6B

Sector

Utilities

ML Signal

HOLD

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$142.33

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ED
A
Founded
1884
1999
Country
United States
United States
Employees
N/A
17900
Industry
Power Generation
Biotechnology: Laboratory Analytical Instruments
Sector
Utilities
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
34.6B
39.8B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ED
A
Price
$95.57
$142.33
Analyst Decision
Hold
Buy
Analyst Count
13
15
Target Price
$104.77
$162.80
AVG Volume (30 Days)
2.5M
2.2M
Earning Date
11-06-2025
11-24-2025
Dividend Yield
3.56%
0.71%
EPS Growth
7.94
3.16
EPS
5.74
4.57
Revenue
$16,593,000,000.00
$6,948,000,000.00
Revenue This Year
$10.88
$7.76
Revenue Next Year
$3.55
$6.24
P/E Ratio
$16.63
$31.39
Revenue Growth
10.39
6.73
52 Week Low
$87.28
$96.43
52 Week High
$114.87
$160.27

Technical Indicators

Market Signals
Indicator
ED
A
Relative Strength Index (RSI) 38.18 42.63
Support Level $95.19 $140.22
Resistance Level $96.71 $143.93
Average True Range (ATR) 1.65 4.12
MACD -0.41 -1.36
Stochastic Oscillator 7.33 10.72

Price Performance

Historical Comparison
ED
A

About ED Consolidated Edison Inc.

Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: